{"id":"https://openalex.org/W7207846466","doi":"https://doi.org/10.1177/09564624261485266","title":"Anti\u2013IL-17 therapy in people living with HIV who have cutaneous psoriasis: A four-patient case series","display_name":"Anti\u2013IL-17 therapy in people living with HIV who have cutaneous psoriasis: A four-patient case series","publication_year":2026,"publication_date":"2026-09-03","ids":{"openalex":"https://openalex.org/W7207846466","doi":"https://doi.org/10.1177/09564624261485266","pmid":"https://pubmed.ncbi.nlm.nih.gov/42687559"},"language":"en","primary_location":{"id":"doi:10.1177/09564624261485266","doi":"https://doi.org/10.1177/09564624261485266","is_oa":false,"landing_page_url":"https://doi.org/10.1177/09564624261485266","pdf_url":null,"source":{"id":"https://openalex.org/S30045969","display_name":"International Journal of STD & AIDS","issn_l":"0956-4624","issn":["0956-4624","1758-1052"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of STD & AIDS","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5116739877","display_name":"Melike Merve G\u00fc\u00e7l\u00fc","orcid":"https://orcid.org/0009-0009-8998-2138","observed_orcids":["https://orcid.org/0009-0009-8998-2138"]},"institutions":[{"id":"https://openalex.org/I4387154896","display_name":"\u0130zmir Demokrasi \u00dcniversitesi","ror":"https://ror.org/04c152q53","country_code":"TR","type":"education","lineage":["https://openalex.org/I4387154896"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Melike Merve G\u00fc\u00e7l\u00fc","raw_affiliation_strings":["Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital"],"raw_orcid":"https://orcid.org/0009-0009-8998-2138","affiliations":[{"raw_affiliation_string":"Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital","institution_ids":["https://openalex.org/I4387154896"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077232857","display_name":"Fatma Asl\u0131 Hapa","orcid":"https://orcid.org/0000-0003-4145-9259","observed_orcids":["https://orcid.org/0000-0003-4145-9259"]},"institutions":[{"id":"https://openalex.org/I4387154896","display_name":"\u0130zmir Demokrasi \u00dcniversitesi","ror":"https://ror.org/04c152q53","country_code":"TR","type":"education","lineage":["https://openalex.org/I4387154896"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Fatma Asl\u0131 Hapa","raw_affiliation_strings":["Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital","institution_ids":["https://openalex.org/I4387154896"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041703156","display_name":"Fatma Elif Y\u0131ld\u0131r\u0131m","orcid":"https://orcid.org/0000-0001-6801-8491","observed_orcids":["https://orcid.org/0000-0001-6801-8491"]},"institutions":[{"id":"https://openalex.org/I4210135744","display_name":"Sanko University","ror":"https://ror.org/04a94ee43","country_code":"TR","type":"education","lineage":["https://openalex.org/I4210135744"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Fatma Elif Y\u0131ld\u0131r\u0131m","raw_affiliation_strings":["Sanko Universitesi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanko Universitesi","institution_ids":["https://openalex.org/I4210135744"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.56865986,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"9564624261485266","last_page":"9564624261485266"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-il-17-therapy","display_name":"anti-IL-17 therapy","score":0.9739999771118164},{"id":"https://openalex.org/keywords/il-17","display_name":"IL-17","score":0.8259999752044678},{"id":"https://openalex.org/keywords/cutaneous-psoriasis","display_name":"cutaneous psoriasis","score":0.871999979019165},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.7409999966621399},{"id":"https://openalex.org/keywords/secukinumab","display_name":"secukinumab","score":0.9890000224113464},{"id":"https://openalex.org/keywords/ixekizumab","display_name":"ixekizumab","score":1.0},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.8840000033378601},{"id":"https://openalex.org/keywords/hiv-viral-load","display_name":"HIV viral load","score":0.8199999928474426},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.9350000023841858},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.6740000247955322},{"id":"https://openalex.org/keywords/pasi","display_name":"PASI","score":0.7429999709129333}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.958899974822998},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7139000296592712},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6862999796867371},{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.5551000237464905},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5454000234603882},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.5418000221252441},{"id":"https://openalex.org/C2780648854","wikidata":"https://www.wikidata.org/wiki/Q2745824","display_name":"Immunopathology","level":2,"score":0.47600001096725464},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.45159998536109924},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.44449999928474426},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4318999946117401},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.41620001196861267},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.40639999508857727},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.4047999978065491},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.3255999982357025},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.3248000144958496},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3174000084400177},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.310699999332428},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.30820000171661377},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.29269999265670776},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2800000011920929},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.27639999985694885}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1177/09564624261485266","doi":"https://doi.org/10.1177/09564624261485266","is_oa":false,"landing_page_url":"https://doi.org/10.1177/09564624261485266","pdf_url":null,"source":{"id":"https://openalex.org/S30045969","display_name":"International Journal of STD & AIDS","issn_l":"0956-4624","issn":["0956-4624","1758-1052"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of STD & AIDS","raw_type":"journal-article"},{"id":"pmid:42687559","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42687559","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of STD & AIDS","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W2034453891","https://openalex.org/W2046104359","https://openalex.org/W2125681068","https://openalex.org/W2924655717","https://openalex.org/W2945980288","https://openalex.org/W3037044416","https://openalex.org/W3045375097","https://openalex.org/W3048757282","https://openalex.org/W3110282914","https://openalex.org/W4281739655","https://openalex.org/W4282934667","https://openalex.org/W4283220154","https://openalex.org/W4313319677","https://openalex.org/W4384834033","https://openalex.org/W4403616379","https://openalex.org/W4404311415","https://openalex.org/W4404772386","https://openalex.org/W4413447094"],"related_works":["https://openalex.org/W4313319677","https://openalex.org/W3048757282","https://openalex.org/W4214736838","https://openalex.org/W4384834033","https://openalex.org/W4413447094","https://openalex.org/W4404772386","https://openalex.org/W4253514282","https://openalex.org/W1849511347","https://openalex.org/W2896224253","https://openalex.org/W1970037800"],"abstract_inverted_index":{"AimTo":[0],"describe":[1],"the":[2],"clinical,":[3],"immunological,":[4],"virological":[5,114],"and":[6,30,56,67],"safety":[7,129],"outcomes":[8],"observed":[9,99,109],"during":[10,100],"anti-IL-17":[11,34],"therapy":[12,102],"in":[13,38,73,111,116],"patients":[14,22,64],"living":[15,23],"with":[16,24,33,105],"HIV":[17,25,51,85],"who":[18,26],"had":[19,27],"cutaneous":[20,28],"psoriasis.MethodFour":[21],"psoriasis":[29],"were":[31,36,59,98],"treated":[32],"agents":[35],"included":[37],"this":[39,117],"case":[40,119],"series.":[41,120],"Psoriasis":[42,71],"Area":[43],"Severity":[44],"Index":[45],"(PASI)":[46],"scores,":[47],"CD4":[48,77],"cell":[49,78],"counts,":[50],"RNA":[52,86],"levels,":[53],"treatment":[54],"duration":[55],"adverse":[57,96],"events":[58,97],"obtained":[60],"from":[61],"medical":[62],"records.ResultsThree":[63],"received":[65,69],"secukinumab":[66],"one":[68],"ixekizumab.":[70],"improved":[72],"all":[74],"four":[75],"patients.":[76],"counts":[79],"remained":[80,88],"stable":[81],"or":[82,90,113],"increased,":[83],"while":[84],"levels":[87],"suppressed":[89],"declined":[91],"following":[92],"antiretroviral":[93],"therapy.":[94],"No":[95],"follow-up.ConclusionAnti-IL-17":[101],"was":[103],"associated":[104],"clinical":[106],"improvement":[107],"without":[108],"deterioration":[110],"immunological":[112],"parameters":[115],"small":[118],"Larger":[121],"prospective":[122],"studies":[123],"are":[124],"required":[125],"before":[126],"conclusions":[127],"regarding":[128],"can":[130],"be":[131],"drawn.":[132]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-09-04T00:00:00"}